ESR1 and endometrial cancer: Like MDA-MB-231 two endometrial cancer cell lines (RL92-2, MFE) that were evaluated also lacked endogenous ERα mRNAs but had much higher concentrations of ERβ5 which made them unsuitable for the transfection study.